
Sun Pharma unveils cough syrup
The Hindu
Company claims it gives relief for up to 12 hours
Sun Pharmaceutical Industries Ltd. has announced the introduction of a formulation in cough management — Chericof 12 (Dextromethorphan Hydrobromide 30 mg and Chlorpheniramine Maleate 4 mg in India. The company said this was the first prescription cough syrup in India that gave relief for up to 12 hours.
It is manufactured using Polistirex technology for sustained release of the drug which is approved for patients aged six years and above. “All cough syrups generally give relief for 6-8 hours, and hence a patient has to take it three to four times a day. Frequent dosing often leads to patient inconvenience and non-adherence to follow the regimen, which may compromise the efficacy of the medication and disturb the daily lifestyle,” the company said in a statement.
Kirti Ganorkar, CEO – India Business, Sun Pharma said, “The Polistirex technology used in Chericof® 12 helps in improving patient compliance and avoids the need for frequent dosing.”

The Karnataka government has drafted a comprehensive master plan for the integrated development of Kukke Subrahmanya temple, the State’s highest revenue-generating temple managed by the Hindu Religious Institutions and Charitable Endowments Department. The redevelopment initiative is estimated to cost around ₹254 crore and aims to enhance infrastructure and facilities for devotees.